Introduction: Dysmenorrhea has been defined as painful cramping during menstruation and is a prevalent problem among women affecting their quality of life. In alleviating menstrual pain, most modern techniques rely on medications or lifestyle changes. However, literature has started emerging highlighting the prospective benefits that calcium could provide in alleviating the effects of excessive dysmenorrhea. This cross-sectional study attempts to fill this void by investigating calcium’s ability to modify the symptoms of dysmenorrhea. Objective: This study aims its first aim to establish whether calcium intake is a protective or risk factor for dysmenorrhea severity in reproductive-aged women poets. More specifically, the study will seek to examine the associations between various calcium levels within a woman’s body and the malady of uncomfortable menstrual periods. Results: Between the aforementioned groups of women, the calcium-rich group had much lower self-reported dysmenorrhea pain scores (p < 0.01). Conversely, there was some evidence of achieving greater pain-scores reduction, by the amount that averaged 25% among high-calcium consumers, with the increase of calcium levels. The analysis also revealed that all participants treated with calcium significantly increased the efficacy of dysmenorrhea management by 30% in the clinical trial with the most severe category of dysmenorrhea. Discussion: Considering the current data, it can be recognized that calcium may alleviate symptoms in women with dysmenorrhea and therefore, can be utilized as an adjunct. Since pain severity decreased and the management of symptoms was more efficient, this could be explained by a modification of muscle contraction and prostaglandin production by calcium. To the best of our knowledge, this study presents something new and unique evidence in that it demonstrates and establishes calcium consumption affects relief in dysmenorrhea – which previous studies have not documented satisfactorily. Conclusion: This cross-sectional study demonstrates the possible role of calcium in altering the recurrent pain experienced by women. Such a declining trend in dysmenorrhea with increased calcium intake is very promising, and the wish to unravel further mechanisms e.g., how else calcium can elicit how pain is modulated is certainly a fantasy waiting to be fulfilled. These results reinforce the need to add calcium supplementation to dysmenorrhea treatment plans that will encourage improvement in women’s health.